Wockhardt share price has zoomed 5% and is presently trading at Rs 1,231.0.
Meanwhile, the BSE HEALTHCARE index is at 42,664.5 (up 0.5%).
Among the top gainers in the BSE HEALTHCARE index today are APOLLO HOSPITALS (up 2.0%) and LAURUS LABS (up 1.9%).
ALKEM LABORATORIES (down 0.8%) and Natco Pharma (down 0.7%) are among the top losers today.
Over the last one year, Wockhardt has moved up from Rs 330.7 to Rs 1,231.0, registering a gain of Rs 900.3 (up 272.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 29,583.1 to 42,664.5, registering a gain of 44.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 158.7%), SUVEN PHARMACEUTICALS (up 115.8%) and FORTIS HEALTHCARE (up 89.5%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 77,459.6 (up 0.4%).
The top gainers among the BSE Sensex today are ICICI Bank (up 1.6%) and SBI (up 1.5%). The most traded stocks in the BSE Sensex are MUNDRA PORT & SEZ and Tata Steel.
In the meantime, NSE Nifty is at 23,455.1 (up 0.5%). APOLLO HOSPITALS and Power Grid Corp. are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,655.2 to 77,459.6, registering a gain of 11,804.5 points (up 18.0%).
Wockhardt net profit grew 78.1% YoY to Rs -160 million for the quarter ended September 2024, compared to a loss of Rs 730 million a year ago. Net sales rose 7.4% to Rs 8,090 million during the period as against Rs 7,530 million in July-September 2023.
For the year ended March 2024, Wockhardt reported 24.0% increase in net profit to Rs -4,720 million compared to net loss of Rs 6,210 million during FY23. Revenue of the company grew 5.5% to Rs 27,980 million during FY24.
The current Price to earnings ratio of Wockhardt, based on rolling 12 month earnings, stands at -67.8.
Equitymaster requests your view! Post a comment on "Wockhardt Gains 5%; BSE HEALTHCARE Index Up 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!